Bone morphogenetic protein-7 release from endogenous neural precursor cells suppresses the tumourigenicity of stem-like glioblastoma cellsBrain, Jul 2010; 133: 1961 - 1972
[Brain Cancer Panel I ]
Global analysis of microarray data reveals intrinsic properties in gene expression and tissue selectivityBioinformatics, Jul 2010; 26: 1723 - 1730.
[Cancer Survey Panel 384 - I ]
Kelch-like homologue 9 mutation is associated with an early onset autosomal dominant distal myopathyBrain, Jul 2010; 133: 2123 - 2135
[HSCA101]
Accurate interpretation of your experimental data depends on the quality of the tissue or tissue-derived product, as well as the quality of the associated data annotation. Our quality system encompasses all aspects of the biospecimen life cycle from collection and pathology evaluation through derivative processing and product distribution.
Tissue Collection
OriGene believes that the proper collection and use of human biospecimens begins with the complete protection of the rights and privacy of the individual.
All samples are collected under IRB approved protocols
All human subjects are fully informed and are explicitly asked for their consent to future research use of their samples, even in cases where such uses are unknown at the time
De-identified and coded patient numbers (Case IDs) ensure the privacy of our donors in accordance with the Health Insurance Portability and Accountability Act (HIPAA)
Samples are collected from a diverse set of medical institutions throughout the United States in order to maximize patient diversity
Frozen samples are embedded in OCT media to facilitate sectioning and pathology verification
Detailed pathology reports are abstracted and meticulously reviewed to confirm patient diagnosis
Standardized clinical ontology imparts greater confidence in product selection
A pathologist performs a microscopic evaluation of each and every sample to ensure the accuracy of the sample level diagnosis (i.e., a normal adjacent sample collected from a cancer patient) and detail the
sample’s cellularity (% normal cells, % lesion cells, % tumor cells, % stroma and % necrosis)
Confirmation and description of the tissue of origin and site of finding is provided for every sample
OriGene provides a highly detailed presentation of sample data including hyperlinks to abstracted pathology reports and digital H&E images.
Clients may elect to work interactively with a customer service professional to identify the most appropriate samples for a given study
Secure, convenient downloading of sample presentations via OriGene ServiceWeb
Biorepository Management
The OriGene Biorepository employs numerous practices and features designed to minimize the likelihood of an event that could result in the loss of sample integrity
All sample movements within the Biorepository are 100% traceable making it possible to quickly and easily review the current location as well as the entire location history of each and every sample in the Biorepository
Redundant AC: Building and additional heat exchangers
Auxiliary power: Diesel generator activated within seconds of a power outage
24 hour monitoring of ambient and freezer temperatures, power and noise levels and automated telephone notification in the event of a deviation
24/7 emergency freezer service and freezer re-location service
Tissue Derivatives
Each sample is carefully reviewed by a pathologist prior to derivative extraction. The description of the source sample cellularity along with digital images of the H&E slide are provided for each sample
Our highly purified total RNA is suitable for gel based analysis, real-time PCR analysis and microarray analysis
RNA quality is assessed using an Agilent Bioanalyzer
RNA 28S/18S ratio, Agilent Bioanalyzer electropherogram (in .jpg format) and RIN score (coming soon) are provided for each sample
RT-PCR is performed for each sample to demonstrate suitability for cDNA based expression analysis and the absence of contaminating genomic DNA
All sectioning work is performed by ASCP licensed histologists
Proven, rigorous protocols ensure that frozen tissue is not allowed to thaw during the cutting, storing and shipping processes
Each sectioning order is reviewed by a pathologist prior to shipment to ensure that freeze artifact is not present (in frozen samples) and that the cellularity is representative of the source block
Product Distribution
The OriGene Biorepository has served as a hub for the collection, management and distribution of nearly 200,000 biospecimens
All Biorepository personnel are specifically trained and certified for the handling of class 6.2 dangerous goods
All shipments sent from the OriGene meet or exceed International Air Transport Association (IATA) guidelines